Literature DB >> 1864592

Hepatic fibrin-ring granulomas: a clinicopathologic study of 23 patients.

M Marazuela1, A Moreno, M Yebra, E Cerezo, C Gómez-Gesto, J A Vargas.   

Abstract

Twenty-three patients with characteristic hepatic fibrin-ring granulomas were studied. Q fever accounted for 10 cases (43%), visceral leishmaniasis for five cases (22%), boutonneuse fever for two cases (9%), and toxoplasmosis, Hodgkin's disease, and allopurinol hypersensitivity for one case each (4%). The etiology remained undetermined in three cases (13%). This report broadens the range of etiologies of hepatic fibrin-ring granulomas to include boutonneuse fever and toxoplasmosis in the differential diagnosis of ring granulomas, and it could serve as a guideline to the clinician and pathologist for the most frequent categories of disease associated with this morphologic pattern.

Entities:  

Mesh:

Year:  1991        PMID: 1864592     DOI: 10.1016/0046-8177(91)90240-p

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  4 in total

1.  Dynamic imaging of experimental Leishmania donovani-induced hepatic granulomas detects Kupffer cell-restricted antigen presentation to antigen-specific CD8 T cells.

Authors:  Lynette Beattie; Adam Peltan; Asher Maroof; Alun Kirby; Najmeeyah Brown; Mark Coles; Deborah F Smith; Paul M Kaye
Journal:  PLoS Pathog       Date:  2010-03-12       Impact factor: 6.823

2.  Hepatic sarcoidosis complicating treatment-naive viral hepatitis.

Authors:  Aloysious Aravinthan; William Gelson; Anita Limbu; Rebecca Brais; Paul Richardson
Journal:  World J Hepatol       Date:  2012-12-27

3.  An unusual occurrence of hepatic granulomas and secondary sitosterolemia in turner syndrome.

Authors:  JayaKrishna Chintanaboina; Pragnesh R Shah; Thomas R Riley
Journal:  Case Rep Med       Date:  2015-01-29

Review 4.  Allopurinol hypersensitivity: a systematic review of all published cases, 1950-2012.

Authors:  Sheena N Ramasamy; Cameron S Korb-Wells; Diluk R W Kannangara; Myles W H Smith; Nan Wang; Darren M Roberts; Garry G Graham; Kenneth M Williams; Richard O Day
Journal:  Drug Saf       Date:  2013-10       Impact factor: 5.228

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.